Literature DB >> 24155493

A case of necrolytic migratory erythema managed for 24 months with intravenous amino acid and lipid infusions.

Jonathan F Bach1, Seth A Glasser.   

Abstract

A 9-year-old castrated male Shetland sheepdog was diagnosed with necrolytic migratory erythema and hepatocutaneous syndrome. Necrolytic migratory erythema was treated with intermittent intravenous amino acids as needed to control cutaneous lesions. The addition of lipid infusions extended the treatment interval. The patient had a favorable response for 24 months.

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24155493      PMCID： PMC3743574     

Source DB:  PubMed          Journal:  Can Vet J        ISSN： 0008-5286            Impact factor:   1.008


  12 in total

1.  Glucagon-producing neuroendocrine tumour associated with hypoaminoacidaemia and skin lesions.

Authors:  K Allenspach; P Arnold; T Glaus; B Hauser; C Wolff; C Eberle; P Komminoth
Journal:  J Small Anim Pract       Date:  2000-09       Impact factor: 1.522

2.  Plasma amino acid concentrations in 36 dogs with histologically confirmed superficial necrolytic dermatitis.

Authors:  Catherine A Outerbridge; Stanley L Marks; Quinton R Rogers
Journal:  Vet Dermatol       Date:  2002-08       Impact factor: 1.589

3.  Successful treatment of canine necrolytic migratory erythema (superficial necrolytic dermatitis) due to metastatic glucagonoma with octreotide.

Authors:  Ursula Oberkirchner; Keith E Linder; Leah Zadrozny; Thierry Olivry
Journal:  Vet Dermatol       Date:  2010-05-24       Impact factor: 1.589

4.  Successful treatment of a patient with octreotide-resistant necrolytic migratory erythema.

Authors:  A P Bewley; J S Ross; C B Bunker; R C Staughton
Journal:  Br J Dermatol       Date:  1996-06       Impact factor: 9.302

Review 5.  Metabolic epidermal necrosis-hepatocutaneous syndrome.

Authors:  K P Byrne
Journal:  Vet Clin North Am Small Anim Pract       Date:  1999-11       Impact factor: 2.093

6.  Glucagon-producing pancreatic endocrine tumors in two dogs with superficial necrolytic dermatitis.

Authors:  T L Gross; T D O'Brien; A P Davies; R E Long
Journal:  J Am Vet Med Assoc       Date:  1990-12-15       Impact factor: 1.936

Review 7.  The skin: an indispensable barrier.

Authors:  Ehrhardt Proksch; Johanna M Brandner; Jens-Michael Jensen
Journal:  Exp Dermatol       Date:  2008-12       Impact factor: 3.960

8.  Superficial necrolytic dermatitis (necrolytic migratory erythema) in dogs.

Authors:  T L Gross; M D Song; P J Havel; P J Ihrke
Journal:  Vet Pathol       Date:  1993-01       Impact factor: 2.221

9.  Superficial necrolytic dermatitis in 11 dogs with a history of phenobarbital administration (1995-2002).

Authors:  Philip A March; Andrew Hillier; Steven E Weisbrode; John S Mattoon; Susan E Johnson; Stephen P DiBartola; Peter J Brofman
Journal:  J Vet Intern Med       Date:  2004 Jan-Feb       Impact factor: 3.333

10.  Superficial necrolytic dermatitis associated with extrapancreatic glucagonoma in a dog.

Authors:  Takuya Mizuno; Hiroko Hiraoka; Chihiro Yoshioka; Yoshiho Takeda; Yuki Matsukane; Natsumi Shimoyama; Masahiro Morimoto; Toshiharu Hayashi; Masaru Okuda
Journal:  Vet Dermatol       Date:  2009-02       Impact factor: 1.589
View more
  2 in total

1.  Treatment and outcomes of dogs with hepatocutaneous syndrome or hepatocutaneous-associated hepatopathy.

Authors:  John P Loftus; Adam J Miller; Sharon A Center; Jeanine Peters-Kennedy; Michael Astor
Journal:  J Vet Intern Med       Date:  2021-11-25       Impact factor: 3.333

2.  Successful Long-Term Management of Canine Superficial Necrolytic Dermatitis With Amino Acid Infusions and Nutritionally Balanced Home-Made Diet Modification.

Authors:  Jared A Jaffey; Robert C Backus; Megan Sprinkle; Catherine Ruggiero; Sylvia H Ferguson; Kate Shumway
Journal:  Front Vet Sci       Date:  2020-01-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.